Kristine Nguyen
Physician Assistant · Alameda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 2 carriers
- Offices
- 4
Offices
4 locations · Csi Medical Group · 104 clinicians in this group
Looking this up.
Plans that list them
7 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kristine Nguyen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G56974 · Current
Licensed to practise in California · since 1986 · expires 2028-01-31 · University of Illinois College of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$173,160
Medicare paid this office $173,160 for 270 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 82 | $22,965 | $100 |
| Short return visit (20+ min) | 160 | $19,192 | $69 |
| Destruction of skin growth, 1-14 growths | 112 | $15,550 | $91 |
| Destruction of precancer skin growth, 1 growth | 82 | $5,043 | $38 |
| New patient visit (30+ min) | 59 | $4,650 | $79 |
See all 17 services
| Return visit (30+ min) | 82 | $22,965 | $100 |
| Short return visit (20+ min) | 160 | $19,192 | $69 |
| Destruction of skin growth, 1-14 growths | 112 | $15,550 | $91 |
| Destruction of precancer skin growth, 1 growth | 82 | $5,043 | $38 |
| New patient visit (30+ min) | 59 | $4,650 | $79 |
| Biopsy of related skin growth, first growth | 49 | $3,567 | $65 |
| Destruction of skin growth, 15 or more growths | 16 | $3,271 | $117 |
| Destruction of precancer skin growth, 15 or more growths | 17 | $2,956 | $134 |
| Destruction of precancer skin growth, 2-14 growths | 60 | $2,530 | $6 |
| New patient visit (45+ min) | 17 | $1,988 | $117 |
| Simple or single drainage of skin abscess | 16 | $1,842 | $102 |
| Punch biopsy, first skin growth | 14 | $1,488 | $99 |
| Injection into skin growth, 1-7 growths | 15 | $861 | $39 |
| Biopsy of related skin growth, each additional growth | 14 | $671 | $42 |
| Injection of drug or substance under skin or into muscle | 11 | $360 | $12 |
| Tissue fungi or parasites | 13 | $67 | $4 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $26 | None |
Procedures Medicare counted
| Removal of skin lesions | 153 | More than 78% of doctors who do this |
| Removal of tissue | 15 | More than 66% of doctors who do this |
| Removal or shaving of skin growth | 15 | More than 68% of doctors who do this |
| Skin biopsy | 30 | More than 66% of doctors who do this |
Who their Medicare patients are
270 Original Medicare patients in 2024. Average age 75 · Women 56% · Also on Medicaid 11% · Health risk score 1.21. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 74% · Diabetes 34% · Chronic kidney disease 28% · Coronary heart disease 26% · Cancer 16% · Atrial fibrillation 16% · Depression 16% · Heart failure 15% · COPD 13% · Dementia 10% · Stroke 9%.
The office billed $417,090, Medicare allowed $224,300 and paid $173,160; for 1,994 services of 71 kinds; $65,303 of it was for drugs given in the office and $107,857 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 270 | 1,994 | 75 | 1.21 | $417,090 | $173,160 |
| 2023 | 247 | 2,003 | 75 | 1.18 | $414,559 | $171,120 |
| 2022 | 178 | 2,289 | 74 | 1.04 | $468,186 | $230,314 |
| 2021 | 220 | 2,292 | 77 | 1.25 | $421,629 | $211,939 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Short return visit (20+ min) | 151 | $18,509 | $64 |
| Return visit (30+ min) | 72 | $14,450 | $94 |
| Destruction of skin growth, 1-14 growths | 77 | $10,646 | $87 |
| New patient visit (30+ min) | 65 | $5,313 | $82 |
| Destruction of precancer skin growth, 1 growth | 83 | $4,838 | $38 |
| Biopsy of related skin growth, first growth | 56 | $4,238 | $65 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 11 | $3,463 | $124 |
| Removal of tissue from wound, 20.0 sq cm or less | 17 | $3,134 | $82 |
| New patient visit (45+ min) | 18 | $2,243 | $125 |
| Destruction of skin growth, 15 or more growths | 12 | $2,223 | $106 |
| Destruction of precancer skin growth, 2-14 growths | 62 | $2,080 | $6 |
| Biopsy of related skin growth, each additional growth | 15 | $873 | $44 |
| Injection into skin growth, 1-7 growths | 14 | $656 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $19 | None |
2022: 13 services
| Puraply am, per square centimeter | 12 | $59,997 | $87 |
| Short return visit (20+ min) | 122 | $19,878 | $67 |
| Return visit (30+ min) | 53 | $9,866 | $97 |
| Destruction of skin growth, 1-14 growths | 61 | $7,752 | $86 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 11 | $7,604 | $125 |
| Destruction of precancer skin growth, 1 growth | 51 | $2,856 | $38 |
| Biopsy of related skin growth, first growth | 34 | $2,102 | $54 |
| Destruction of precancer skin growth, 2-14 growths | 45 | $1,777 | $6 |
| New patient visit (30+ min) | 25 | $1,741 | $70 |
| Removal of inflamed or infected skin, up to 10% of body surface | 12 | $1,527 | $27 |
| Injection into skin growth, 1-7 growths | 20 | $815 | $31 |
| Short return visit | 12 | $551 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $22 | None |
2021: 17 services
| Puraply am, per square centimeter | 15 | $53,817 | $89 |
| Short return visit (20+ min) | 132 | $19,658 | $73 |
| Return visit (30+ min) | 77 | $11,582 | $101 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 12 | $7,668 | $118 |
| Destruction of skin growth, 1-14 growths | 58 | $6,803 | $93 |
| Biopsy of related skin growth, first growth | 51 | $4,482 | $71 |
| Destruction of precancer skin growth, 15 or more growths | 21 | $4,295 | $143 |
| New patient visit (30+ min) | 50 | $3,930 | $79 |
| Destruction of precancer skin growth, 1 growth | 56 | $2,666 | $37 |
| Destruction of skin growth, 15 or more growths | 12 | $2,432 | $116 |
| New patient visit (45+ min) | 23 | $2,368 | $103 |
| Removal of inflamed or infected skin, up to 10% of body surface | 20 | $2,069 | $27 |
| Destruction of precancer skin growth, 2-14 growths | 44 | $1,616 | $6 |
| Punch biopsy, first skin growth | 11 | $1,342 | $112 |
| Biopsy of related skin growth, each additional growth | 15 | $876 | $46 |
| Injection into skin growth, 1-7 growths | 11 | $665 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $35 | None |
Medicaid work
$0 in 2023
Medicaid paid $0 for 18 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 18 | $0 |
| 2023 | 18 | 1 | 15 | $0 |
| 2021 | 14 | 1 | 14 | $0 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 14 | $0 |
Drugs they prescribed that Part D paid
$290,362
Pharmacies billed $290,362 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 610) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
559 generic and 51 brand-name prescriptions · $290,362 in drug cost · 77 antibiotic prescriptions to 36 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 31 | $109,398 | $3,529 |
| Fluocinonide | 81 | $4,802 | $59 |
| Ketoconazole | 68 | $1,623 | $24 |
| Doxycycline Hyclate | 69 | $1,315 | $19 |
| Clobetasol Propionate | 54 | $1,294 | $24 |
See all 13 drugs
| Dupixent | 31 | $109,398 | $3,529 |
| Fluocinonide | 81 | $4,802 | $59 |
| Ketoconazole | 68 | $1,623 | $24 |
| Doxycycline Hyclate | 69 | $1,315 | $19 |
| Clobetasol Propionate | 54 | $1,294 | $24 |
| Metronidazole | 20 | $1,237 | $62 |
| Desonide | 17 | $1,003 | $59 |
| Triamcinolone Acetonide | 93 | $957 | $10 |
| Tacrolimus | 11 | $642 | $58 |
| Mupirocin | 30 | $201 | $7 |
| Cephalexin | 19 | $140 | $7 |
| Hydroxyzine | 17 | $84 | $5 |
| Prednisone | 13 | $48 | $4 |
Year by year
| 2024 | 610 | 156 | 0% (0) | 8% | $290,362 |
| 2023 | 505 | 136 | 0% (0) | 12% | $332,495 |
| 2022 | 554 | 144 | 0% (0) | 6% | $207,515 |
| 2021 | 722 | 168 | 0% (0) | 4% | $145,775 |
| 2020 | 602 | 105 | 0% (0) | 10% | $106,524 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Dupixent | 43 | $159,716 | $3,714 |
| Cosentyx Sensoready (2 Pens) | 11 | $82,122 | $7,466 |
| Fluocinonide | 55 | $3,699 | $67 |
| Clobetasol Propionate | 40 | $2,559 | $64 |
| Doxycycline Hyclate | 30 | $1,348 | $45 |
| Ketoconazole | 53 | $1,064 | $20 |
| Imiquimod | 21 | $988 | $47 |
| Triamcinolone Acetonide | 90 | $940 | $10 |
| Cephalexin | 16 | $501 | $31 |
| Hydroxyzine | 33 | $354 | $11 |
| Mupirocin | 14 | $109 | $8 |
2022: 12 drugs
| Dupixent | 13 | $46,908 | $3,608 |
| Fluocinonide | 62 | $10,759 | $174 |
| Calcipotriene | 11 | $5,560 | $505 |
| Clobetasol Propionate | 54 | $4,892 | $91 |
| Doxycycline Hyclate | 18 | $1,818 | $101 |
| Halobetasol Propionate | 12 | $1,809 | $151 |
| Ketoconazole | 58 | $1,559 | $27 |
| Triamcinolone Acetonide | 104 | $1,428 | $14 |
| Clindamycin Phosphate | 12 | $723 | $60 |
| Mometasone Furoate | 23 | $679 | $30 |
| Hydroxyzine | 54 | $550 | $10 |
| Cephalexin | 19 | $165 | $9 |
2021: 13 drugs
| Fluocinonide | 105 | $14,137 | $135 |
| Calcipotriene | 18 | $8,122 | $451 |
| Clobetasol Propionate | 83 | $6,966 | $84 |
| Ketoconazole | 94 | $2,140 | $23 |
| Betamethasone Dipropionate | 23 | $1,954 | $85 |
| Halobetasol Propionate | 16 | $1,693 | $106 |
| Triamcinolone Acetonide | 104 | $1,621 | $16 |
| Mometasone Furoate | 58 | $1,390 | $24 |
| Ciclopirox | 11 | $432 | $39 |
| Ammonium Lactate | 15 | $404 | $27 |
| Hydroxyzine | 41 | $268 | $7 |
| Hydrocortisone | 11 | $142 | $13 |
| Cephalexin | 15 | $130 | $9 |
2020: 17 drugs
| Enstilar | 13 | $20,347 | $1,565 |
| Tacrolimus | 16 | $8,793 | $550 |
| Fluocinonide | 90 | $8,618 | $96 |
| Diflorasone Diacetate | 12 | $7,881 | $657 |
| Calcipotriene | 31 | $7,319 | $236 |
| Clobetasol Propionate | 81 | $6,502 | $80 |
| Hydrocortisone Butyrate | 11 | $6,136 | $558 |
| Desoximetasone | 45 | $6,099 | $136 |
| Betamethasone Diprop Augmented | 30 | $4,779 | $159 |
| Ketoconazole | 61 | $3,942 | $65 |
| Clindamycin Phosphate | 13 | $3,655 | $281 |
| Doxycycline Hyclate | 13 | $2,412 | $186 |
| Metronidazole | 20 | $2,037 | $102 |
| Halobetasol Propionate | 13 | $1,332 | $102 |
| Ammonium Lactate | 13 | $419 | $32 |
| Mupirocin | 15 | $163 | $11 |
| Hydroxyzine | 11 | $64 | $6 |
Money from drug and device companies
$2,540 in 2025
| 2025 | 16 | 111 | None | $2,540 |
| 2024 | 20 | 352 | $450 | $7,566 |
| 2023 | 20 | 304 | $450 | $7,404 |
| 2022 | 18 | 218 | None | $4,491 |
| 2021 | 17 | 137 | None | $3,536 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $402 | 17 payments
|
| LEO Pharma | Adbry | $328 | 23 payments
|
| Abbvie | Skyrizi | $309 | 14 payments
|
| Galderma Laboratories L.P. | Nemluvio | $278 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $257 | 9 payments
|
| Lilly USA | Taltz | $198 | 9 payments
|
See all 111 published payments
| Abbvie | Meals · 2025-12-31 | Skyrizi | $25 |
| Organon | Meals · 2025-12-23 | None | $30 |
| Janssen Biotech | Education · 2025-12-22 | Tremfya | $100 |
| LEO Pharma | Meals · 2025-12-22 | Adbry | $7 |
| Lilly USA | Meals · 2025-12-17 | None | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-12-17 | Dupixent | $26 |
| LEO Pharma | Meals · 2025-12-17 | Adbry | $15 |
| LEO Pharma | Meals · 2025-12-17 | Adbry | $15 |
| Ucb | Meals · 2025-12-16 | Bimzelx | $23 |
| Janssen Biotech | Meals · 2025-12-15 | Tremfya | $26 |
| Amgen | Meals · 2025-12-11 | Otezla | $27 |
| Janssen Biotech | Meals · 2025-12-10 | Tremfya | $28 |
| Abbvie | Meals · 2025-12-10 | Rinvoq | $32 |
| Galderma Laboratories L.P. | Meals · 2025-12-10 | Nemluvio | $22 |
| Abbvie | Meals · 2025-12-09 | Skyrizi | $25 |
| Organon | Meals · 2025-12-09 | None | $10 |
| Incyte | Meals · 2025-12-04 | Opzelura | $27 |
| Galderma Laboratories L.P. | Meals · 2025-12-03 | Nemluvio | $16 |
| Almirall | Meals · 2025-12-03 | Klisyri | $36 |
| Abbvie | Meals · 2025-11-27 | Skyrizi | $11 |
| Novartis Pharmaceuticals | Meals · 2025-11-25 | Rhapsido | $31 |
| Galderma Laboratories L.P. | Meals · 2025-11-25 | Nemluvio | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-11-20 | Dupixent | $30 |
| Galderma Laboratories L.P. | Meals · 2025-11-19 | Nemluvio | $21 |
| LEO Pharma | Meals · 2025-11-19 | Adbry | $21 |
| Incyte | Meals · 2025-11-17 | Opzelura | $29 |
| Abbvie | Meals · 2025-11-12 | Rinvoq | $31 |
| Ucb | Meals · 2025-11-12 | Bimzelx | $43 |
| Janssen Biotech | Meals · 2025-11-11 | Tremfya | $14 |
| Ucb | Meals · 2025-11-06 | Bimzelx | $26 |
| LEO Pharma | Meals · 2025-11-05 | Adbry | $17 |
| Pfizer | Meals · 2025-11-04 | Cibinqo | $24 |
| Galderma Laboratories L.P. | Meals · 2025-11-04 | Nemluvio | $9 |
| Incyte | Meals · 2025-11-03 | Opzelura | $21 |
| LEO Pharma | Meals · 2025-10-30 | Adbry | $17 |
| LEO Pharma | Meals · 2025-10-28 | Adbry | $21 |
| Abbvie | Meals · 2025-10-27 | Skyrizi | $26 |
| LEO Pharma | Meals · 2025-10-22 | Adbry | $9 |
| LEO Pharma | Meals · 2025-10-13 | Adbry | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-10-08 | Dupixent | $33 |
| Lilly USA | Meals · 2025-10-07 | Taltz | $18 |
| Galderma Laboratories L.P. | Meals · 2025-10-07 | Nemluvio | $19 |
| LEO Pharma | Meals · 2025-10-06 | Adbry | $10 |
| Incyte | Meals · 2025-10-01 | Opzelura | $28 |
| Janssen Biotech | Meals · 2025-09-30 | Tremfya | $16 |
| Abbvie | Meals · 2025-09-30 | Skyrizi | $21 |
| Genzyme | Meals · 2025-09-30 | Dupixent | $25 |
| Janssen Biotech | Meals · 2025-09-29 | Tremfya | $16 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $32 |
| Pfizer | Meals · 2025-09-23 | Cibinqo | $29 |
| Abbvie | Meals · 2025-09-22 | Rinvoq | $12 |
| LEO Pharma | Meals · 2025-09-22 | Adbry | $14 |
| Lilly USA | Meals · 2025-09-15 | Taltz | $30 |
| Lilly USA | Meals · 2025-09-09 | Taltz | $16 |
| LEO Pharma | Meals · 2025-09-08 | Adbry | $13 |
| Janssen Biotech | Meals · 2025-09-02 | Tremfya | $19 |
| Biofrontera | Meals · 2025-09-02 | None | $24 |
| LEO Pharma | Meals · 2025-06-10 | Adbry | $12 |
| LEO Pharma | Meals · 2025-06-05 | Adbry | $11 |
| LEO Pharma | Meals · 2025-05-28 | Adbry | $14 |
| Novartis Pharmaceuticals | Meals · 2025-04-28 | Cosentyx | $27 |
| LEO Pharma | Meals · 2025-04-17 | Adbry | $15 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-03-25 | Cabtreo | $24 |
| Pfizer | Education · 2025-03-19 | Cibinqo | $15 |
| LEO Pharma | Meals · 2025-03-14 | Adbry | $11 |
| LEO Pharma | Meals · 2025-03-14 | Adbry | $15 |
| Janssen Biotech | Meals · 2025-03-06 | Tremfya | $17 |
| Janssen Biotech | Meals · 2025-03-06 | Tremfya | $3 |
| Pfizer | Meals · 2025-03-06 | Cibinqo | $28 |
| Novartis Pharmaceuticals | Meals · 2025-03-05 | Cosentyx | $33 |
| Organon | Meals · 2025-03-05 | Vtama | $16 |
| Genzyme | Meals · 2025-03-04 | Dupixent | $26 |
| Organon | Meals · 2025-03-03 | Vtama | $19 |
| LEO Pharma | Meals · 2025-02-26 | Adbry | $23 |
| Janssen Biotech | Meals · 2025-02-25 | Tremfya | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-02-25 | Libtayo | $25 |
| Janssen Biotech | Meals · 2025-02-24 | Tremfya | $21 |
| Abbvie | Meals · 2025-02-23 | Skyrizi | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-02-21 | Dupixent | $38 |
| Galderma Laboratories L.P. | Meals · 2025-02-19 | Nemluvio | $20 |
| Lilly USA | Meals · 2025-02-18 | Taltz | $16 |
| LEO Pharma | Meals · 2025-02-18 | Adbry | $13 |
| Pfizer | Meals · 2025-02-11 | Cibinqo | $21 |
| Novartis Pharmaceuticals | Meals · 2025-02-10 | Cosentyx | $19 |
| Abbvie | Meals · 2025-02-07 | Rinvoq | $32 |
| Lilly USA | Meals · 2025-02-06 | Taltz | $5 |
| Lilly USA | Meals · 2025-02-06 | Taltz | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-02-05 | Dupixent | $14 |
| Organon | Meals · 2025-02-05 | Vtama | $23 |
| Janssen Biotech | Meals · 2025-02-04 | Tremfya | $28 |
| Janssen Biotech | Meals · 2025-02-04 | Tremfya | $14 |
| Genzyme | Meals · 2025-02-03 | Dupixent | $20 |
| LEO Pharma | Meals · 2025-02-03 | Adbry | $10 |
| Janssen Biotech | Meals · 2025-01-30 | Tremfya | $18 |
| Lilly USA | Meals · 2025-01-30 | Taltz | $34 |
| Abbvie | Meals · 2025-01-29 | Skyrizi | $11 |
| Novartis Pharmaceuticals | Meals · 2025-01-28 | None | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-01-28 | Dupixent | $36 |
| Abbvie | Meals · 2025-01-23 | Skyrizi | $18 |
| Incyte | Meals · 2025-01-23 | Opzelura | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-01-22 | Dupixent | $15 |
| Organon | Meals · 2025-01-21 | Vtama | $28 |
| LEO Pharma | Meals · 2025-01-20 | Adbry | $23 |
| Janssen Biotech | Meals · 2025-01-14 | Tremfya | $8 |
| Abbvie | Meals · 2025-01-14 | Skyrizi | $12 |
| Janssen Biotech | Meals · 2025-01-13 | Tremfya | $27 |
| LEO Pharma | Meals · 2025-01-13 | Adbry | $8 |
| Lilly USA | Meals · 2025-01-09 | Taltz | $33 |
| Galderma Laboratories L.P. | Meals · 2025-01-09 | Nemluvio | $150 |
| Regeneron Healthcare Solutions | Meals · 2025-01-08 | Dupixent | $39 |
| Abbvie | Meals · 2025-01-07 | Rinvoq | $29 |
See earlier years (2024, 2023, 2022, 2021)
2024: $7,566
| Janssen Biotech | Tremfya | $1,350 | 63 payments
|
| LEO Pharma | Adbry | $1,286 | 72 payments
|
| Abbvie | Skyrizi | $1,187 | 53 payments
|
| Regeneron Healthcare Solutions | Dupixent | $528 | 20 payments
|
| Sun Pharmaceutical Industries | Ilumya | $446 | 17 payments
|
| Lilly USA | Taltz | $443 | 20 payments
|
| Genzyme | Dupixent | $423 | 15 payments
|
| Dermavant Sciences | Vtama | $326 | 18 payments
|
| Novartis Pharmaceuticals | Cosentyx | $314 | 16 payments
|
| Amgen | Otezla | $284 | 10 payments
|
| Incyte | Opzelura | $207 | 13 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $172 | 9 payments
|
| Pfizer | Eucrisa | $155 | 8 payments
|
| Almirall | Klisyri | $101 | 4 payments
|
| Galderma Laboratories L.P. | None | $96 | 5 payments
|
| Arcutis Biotherapeutics | Zoryve | $80 | 4 payments
|
| Organogenesis | None | $58 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $47 | 2 payments
|
| Genentech USA | Actemra | $37 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $25 | 1 payment
|
2023: $7,404
| LEO Pharma | Adbry | $1,546 | 70 payments
|
| Abbvie | Skyrizi | $951 | 49 payments
|
| Organogenesis | Puraply | $863 | 27 payments
|
| Janssen Biotech | Tremfya | $574 | 18 payments
|
| Dermavant Sciences | Vtama | $545 | 20 payments
|
| Regeneron Healthcare Solutions | Dupixent | $503 | 19 payments
|
| Genzyme | Dupixent | $438 | 16 payments
|
| Novartis Pharmaceuticals | Cosentyx | $388 | 18 payments
|
| Lilly USA | Taltz | $381 | 16 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $224 | 9 payments
|
| Incyte | Opzelura | $211 | 10 payments
|
| Arcutis Biotherapeutics | None | $208 | 5 payments
|
| Sun Pharmaceutical Industries | Absorica Ld | $207 | 10 payments
|
| Pfizer | Eucrisa | $166 | 8 payments
|
| Almirall | Klisyri | $52 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $42 | 2 payments
|
| Journey Medical | None | $28 | 2 payments
|
| Amgen | Otezla | $26 | 1 payment
|
| Ucb | Bimzelx | $25 | 1 payment
|
| Galderma Laboratories L.P. | None | $24 | 1 payment
|
2022: $4,491
| LEO Pharma | Adbry | $853 | 51 payments
|
| Abbvie | Skyrizi | $839 | 34 payments
|
| Novartis Pharmaceuticals | Cosentyx | $423 | 25 payments
|
| Regeneron Healthcare Solutions | Dupixent | $409 | 14 payments
|
| Sun Pharmaceutical Industries | Ilumya | $351 | 13 payments
|
| Galderma Laboratories L.P. | Epsolay | $239 | 9 payments
|
| Journey Medical | Qbrexza | $234 | 19 payments
|
| Janssen Biotech | Tremfya | $233 | 13 payments
|
| Genzyme | Dupixent | $214 | 11 payments
|
| Incyte | Opzelura | $163 | 8 payments
|
| Lilly USA | Taltz | $154 | 7 payments
|
| Ucb | Cimzia | $137 | 6 payments
|
| Organogenesis | Puraply | $79 | 3 payments
|
| Janssen Scientific Affairs | Tremfya | $60 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $31 | 1 payment
|
| Pfizer | Eucrisa | $28 | 1 payment
|
| Dermavant Sciences | Vtama | $24 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $20 | 1 payment
|
2021: $3,536
| AbbVie | Skyrizi | $1,044 | 34 payments
|
| Sun Pharmaceutical Industries | Absorica Ld | $455 | 28 payments
|
| Galderma Laboratories L.P. | Aklief | $344 | 14 payments
|
| Regeneron Healthcare Solutions | Dupixent | $247 | 12 payments
|
| Lilly USA | Taltz | $247 | 8 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $230 | 4 payments
|
| LEO Pharma | Finacea | $190 | 9 payments
|
| Genzyme | Dupixent | $141 | 8 payments
|
| Incyte | Opzelura | $140 | 1 payment
|
| Janssen Biotech | Remicade | $138 | 7 payments
|
| Ethicon US | Stratafix | $93 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $90 | 4 payments
|
| VYNE Pharmaceuticals | Zilxi | $53 | 2 payments
|
| Nabriva Therapeutics plc | Sivextro | $50 | 2 payments
|
| Pfizer | Eucrisa | $30 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $28 | 1 payment
|
| Mayne Pharma | None | $16 | 1 payment
|
Professional record
- NPI
- 1902461189
- Licence
- CA 56974California G56974: Current · expires 2028-01-31
- Trained
- Touro Un College of Osteopathic Medicine, Vallejo, 2019
- Group
- Csi Medical Group
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 56 Linhaven, Irvine, CA, 92602
- NPI first listed
- 2019-05-03
- NPI last updated
- 2020-12-09
- NPI record certified
- 2020-12-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 39210 State St Ste 218, Fremont, CA, 94538 · 991 Montague Expy Ste 104, Milpitas, CA, 95035